Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentinel Lymph Node Biopsy vs Elective Neck Dissection for Early-Stage Oral Cavity Cancer
NCT04333537Phase 3Recruiting
- Sponsor
- NRG Oncology
- Start
- Sep 2020
- Primary completion
- Apr 2031
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in oral cavity squamous cell carcinoma (OCSCC) (2 arms), sponsored by NRG Oncology. Primary endpoints: Neck Dissection Impairment Index at 12 months, Quality of Life at 12 months and 1 more. Started Sep 2020; status: recruiting.
02
Conditions
oral cavity squamous cell carcinoma (OCSCC)
Beyond the preview
Go deeper on NCT04333537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04333537.